ALLYSON UNDERWOOD: Open Payments
NPI 1639302250 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 78 payments from 18 companies in 2025. Trend: 2023 $1,457 · 2024 $1,700 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $249 |
| ABBVIE INC. | 13 | $239 |
| AstraZeneca Pharmaceuticals LP | 9 | $189 |
| UCB, Inc. | 7 | $158 |
| Janssen Biotech, Inc. | 5 | $114 |
| Mallinckrodt Hospital Products Inc. | 4 | $110 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Radius Health, Inc. | 2 | $69 |
Products named: SAPHNELO, Bimzelx, RINVOQ, TREMFYA, ACTHAR, BENLYSTA, OTEZLA, COSENTYX.
Industry payments across GA — which companies pay providers there.
